Inactive Instrument

RISE Life Science Corp. Stock

RLSC

CA76761F1053

Latest news about RISE Life Science Corp.

Britannia Bud Canada Holdings Inc. completed the acquisition of RISE Life Science Corp. in a reverse merger transaction.	21-11-11	CI
RISE Life Science Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2021	21-11-01	CI
Scientus Pharma Inc. cancelled the acquisition of RISE Life Science Corp. in a reverse merger transaction.	21-10-29	CI
RISE Life Science Corp. Appoints Greg Taylor as Board of Director	21-09-01	CI
RISE Life Science Corp. Reports Earnings Results for the Second Quarter Ended May 31, 2021	21-07-29	CI
Rise Life Science Corp. Reports Earnings Results for the First Quarter Ended February 28, 2021	21-04-28	CI
RISE Life Science Corp. announced that it has received $1.331 million in funding	21-04-14	CI
Rise Life Science Corp. Reports Earnings Results for the Full Year Ended November 30, 2020	21-03-29	CI
RISE Life Science Corp. announced that it expects to receive $0.71 million in funding	21-03-03	CI
Britannia Bud Canada Holdings Inc. entered into a Letter of intent to acquire RISE Life Science Corp. in a reverse merger transaction.	21-01-21	CI
Rise Life Science Corp. Reports Earnings Results for the Third Quarter Ended August 31, 2020	20-10-30	CI
Rise Life Science Corp. Reports Earnings Results for the Second Quarter Ended May 31, 2020	20-07-28	CI
RISE Life Science Corp. announced that it expects to receive CAD 10 million in funding	20-04-12	CI
Scientus Pharma Inc. entered into a binding letter agreement to acquire RISE Life Science Corp. for CAD 0.3 million in a reverse merger transaction.	20-04-12	CI
Rise Life Science Corp. Reports Earnings Results for the Full Year Ended November 30, 2019	20-04-05	CI

More news

Press releases RISE Life Science Corp.

IIROC Trade Resumption - BLAB	21-11-17	AQ
CSE Bulletin: Fundamental Change - Rise Life Sciences Corp./Britannia Life Sciences Inc.	21-11-17	NE
Britannia Completes "Go Public" Transaction via Reverse Takeover of Rise Life Sciences and Launches Britannia Life Sciences Inc.	21-11-15	AQ
RISE Life Science : Greg Taylor Joins the Board of RISE Life Science Corp.	21-09-02	AQ
RISE Life Science Corp :. Announces Conversion of Debentures and Debt Settlement	21-06-11	AQ

More press releases

Britannia Life Sciences Inc, formerly RISE Life Science Corp, is a Canada-based vertically diversified product development company. The Company's platform provides an integrated, one-stop shop service for product development, testing, safety & compliance and consumer evaluations/trials. Its principal activities include quality ingredients, formulations, safety assessment, analytical & quality assessments, global compliance and regulation, consumer trials and evaluations for various sectors. It serves Consumer packaged goods (CPG), cosmetics, household goods and nutraceutical industries, blue-chip, food and beverage, nutraceutical sectors, toiletries, small and medium enterprise (SME) clients.

Sector

Food Processing

More about the company

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
ZHEJIANG NHU COMPANY LTD.	+8.20%	7.78B
BELLRING BRANDS, INC.	+0.34%	7.38B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+10.20%	6.52B
BYHEALTH CO., LTD	-8.10%	3.67B
XIAMEN KINGDOMWAY GROUP COMPANY	-14.57%	1.17B
SIRIO PHARMA CO., LTD.	+8.34%	934M
HERBALIFE LTD.	-42.27%	879M
USANA HEALTH SCIENCES, INC.	-18.90%	836M
JAMIESON WELLNESS INC.	-16.45%	802M

Special Foods & Wellbeing Products